Schonfeld Strategic Advisors’s Trillium Therapeutics Inc. TRIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-701,201
| Closed | -$6.8M | – | 2563 |
|
|
2021
Q2 | $6.8M | Buy |
701,201
+187,026
| +36% | +$1.81M | 0.07% | 365 |
|
|
2021
Q1 | $5.52M | Sell |
514,175
-57,500
| -10% | -$618K | 0.07% | 364 |
|
|
2020
Q4 | $8.41M | Buy |
571,675
+2,521
| +0.4% | +$37.1K | 0.11% | 253 |
|
|
2020
Q3 | $8.09M | Buy |
569,154
+169,654
| +42% | +$2.41M | 0.15% | 176 |
|
|
2020
Q2 | $3.23M | Buy |
399,500
+229,500
| +135% | +$1.86M | 0.08% | 277 |
|
|
2020
Q1 | $687K | Buy |
+170,000
| New | +$687K | 0.04% | 481 |
|
|
2017
Q1 | – | Sell |
-22,047
| Closed | -$125K | – | 784 |
|
|
2016
Q4 | $125K | Buy |
22,047
+2,047
| +10% | +$11.6K | 0.02% | 520 |
|
|
2016
Q3 | $296K | Hold |
20,000
| – | – | 0.05% | 318 |
|
|
2016
Q2 | $180K | Buy |
20,000
+9,159
| +84% | +$82.4K | 0.04% | 385 |
|
|
2016
Q1 | $100K | Buy |
+10,841
| New | +$100K | 0.04% | 286 |
|